Back to results
US 10,093,895 B2Granted
Hepatic stellate cell precursors and methods of isolating same
AssigneeThe University of North Carolina at Chapel Hill
InventorsHiroshi Kubota, Lola M. Reid
Life of this patent
Estimating the term…
Abstract
The present invention relates to precursor cells to hepatic stellate cells, compositions comprising same and methods of isolating same. The surface antigenic profile of the precursors is MHC class Ia negative, ICAM-1+, VCAM-1+, β3-integrin+. In addition to expression of these surface markers, the cells also express the intracellular markers desmin, vimentin, smooth muscle α-actin, nestin, hepatocyte growth factor, stromal derived factor-1α and Hlx homeobox transcriptional factor.
Claims3
A medium for propagating hepatic stellate cells and precursors thereof comprising:
- (a) a 1:1 mixture of Dulbecco's modified Eagle's medium and Ham's F12;
- (b) 2 mg/ml bovine serum albumin;
- (c) 5 μg/ml insulin;
- (d) 10−6 M dexamethasone;
- (e) 10 μg/ml iron-saturated transferrin;
- (f) 4.4×10−3 M nicotinamide;
- (g) 5×10−5 M 2-mercaptoethanol;
- (h) 7.6 μeq/l free fatty acid selected from the group consisting of palmitic, palmitoleic, stearic, oleic, linoleic, and linolenic acid;
- (i) 2×10−3 M glutamine;
- (j) 1×10−6 M CuSO4;
- (k) 3×10−8 M Na2SeO3;
- (l) penicillin and streptomycin;
- (m) 10 ng/ml human leukemia inhibitory factor (LIF);
- and
- (n) 10 ng/ml epidermal growth factor (EGF).
12 more elements
Dependencies are inferred from the claim text.